Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer-Reference-Cited by-同舟云学术

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

Published:2019-04-18 Issue:1 Volume:39 Page:21
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Wu Tong¹²,Wu Xuan³⁴,Wang Hong-Yang¹²,Chen Lei¹²

Affiliation:

1. International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute; Second Military Medical University; Shanghai 200438 P. R. China

2. National Center for Liver Cancer; Shanghai 201805 P. R. China

3. Central Laboratory; Shanghai Tenth People's Hospital, Tongji University; Shanghai 200070 P. R. China

4. Department of Laboratory Medicine; Shanghai Tenth People's Hospital, Tongji University; Shanghai 200070 P. R. China

Funder

State Key Project for Liver Cancer

National Research Program of China

National Natural Science Foundation of China

National Natural Science Foundation of Shanghai

the state Key project for liver cancer

the National Research Program of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-019-0365-9.pdf

Reference117 articles.

1. The tumour microenvironment as a target for chemoprevention;Albini;Nat Rev Cancer,2007

2. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review;Vaupel;Cancer Res.,1989

3. The immune contexture in cancer prognosis and treatment;Fridman;Nat Rev Clin Oncol.,2017

4. Implications of the tumor immune microenvironment for staging and therapeutics;Taube;Mod Pathol,2018

5. Releasing the brakes on cancer immunotherapy;Littman;Cell,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of single-cell RNA and bulk RNA sequencing based on M2 tumor-associated macrophage and angiogenesis-related genes to assess prognosis and therapeutic response in lung adenocarcinoma;Heliyon;2024-07

2. Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy;Frontiers in Immunology;2023-12-04

3. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system;BMC Health Services Research;2023-10-11

4. Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment;Nature Reviews Urology;2023-08-21

5. Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability;BMC Medicine;2023-04-27